The metabolism of Ambroxol can be decreased when combined with Diltiazem. The metabolism of Ambroxol can be decreased when combined with Clemastine. The risk or severity of adverse effects can be increased when Methysergide is combined with Ambroxol. The serum concentration of Ambroxol can be decreased when it is combined with Tocilizumab. The serum concentration of Ambroxol can be decreased when it is combined with Deferasirox. The metabolism of Ambroxol can be decreased when combined with Doxycycline. The metabolism of Ambroxol can be decreased when combined with Telithromycin. The risk or severity of adverse effects can be increased when Pergolide is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Darunavir. The metabolism of Ambroxol can be decreased when combined with Amiodarone. The serum concentration of Ambroxol can be increased when it is combined with Fusidic Acid. The serum concentration of Ambroxol can be decreased when it is combined with St. John's Wort. The serum concentration of Pitavastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Delavirdine. The risk or severity of adverse effects can be increased when Ergotamine is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Nelfinavir. The metabolism of Ambroxol can be decreased when combined with Clotrimazole. The serum concentration of Ambroxol can be increased when it is combined with Simeprevir. The metabolism of Ambroxol can be decreased when combined with Bortezomib. The risk or severity of adverse effects can be increased when Ambroxol is combined with Atorvastatin. The metabolism of Ambroxol can be increased when combined with Pentobarbital. The serum concentration of Pravastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Cobicistat. The serum concentration of Simvastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Venlafaxine. The metabolism of Ambroxol can be decreased when combined with Erythromycin. The metabolism of Ambroxol can be decreased when combined with Dihydroergotamine. The metabolism of Ambroxol can be increased when combined with Fosphenytoin. The metabolism of Ambroxol can be decreased when combined with Ketoconazole. The serum concentration of Ambroxol can be increased when it is combined with Osimertinib. The therapeutic efficacy of Ambroxol can be decreased when used in combination with Sarilumab. The metabolism of Ambroxol can be decreased when combined with Boceprevir. The serum concentration of Mevastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Nilotinib. The metabolism of Ambroxol can be decreased when combined with Indinavir. The metabolism of Ambroxol can be decreased when combined with Dronedarone. The serum concentration of Conivaptan can be increased when it is combined with Ambroxol. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Saquinavir. The serum concentration of Rilpivirine can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be increased when combined with Phenytoin. The metabolism of Ambroxol can be decreased when combined with Olaparib. The serum concentration of Ambroxol can be increased when it is combined with Dasatinib. The metabolism of Ambroxol can be decreased when combined with Ranolazine. The metabolism of Ambroxol can be decreased when combined with Ziprasidone. The serum concentration of Ambroxol can be increased when it is combined with Luliconazole. The metabolism of Ambroxol can be increased when combined with Rifabutin. The serum concentration of Fluvastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be increased when combined with Rifampicin. The metabolism of Ambroxol can be decreased when combined with Clarithromycin. The metabolism of Ambroxol can be decreased when combined with Fosamprenavir. The risk or severity of adverse effects can be increased when Ergonovine is combined with Ambroxol. The risk or severity of adverse effects can be increased when Lysergic Acid Diethylamide is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Atazanavir. The metabolism of Ambroxol can be decreased when combined with Isradipine. The metabolism of Ambroxol can be decreased when combined with Lovastatin. The serum concentration of Ambroxol can be increased when it is combined with Ceritinib. The metabolism of Ambroxol can be decreased when combined with Cyclosporine. The serum concentration of Ambroxol can be decreased when it is combined with Bosentan. The serum concentration of Ambroxol can be increased when it is combined with Fosaprepitant. The metabolism of Ambroxol can be decreased when combined with Fluconazole. The metabolism of Ambroxol can be decreased when combined with Sulfisoxazole. The metabolism of Ambroxol can be increased when combined with Primidone. The serum concentration of Ambroxol can be decreased when it is combined with Enzalutamide. The metabolism of Ambroxol can be increased when combined with Nevirapine. The metabolism of Ambroxol can be decreased when combined with Atomoxetine. The serum concentration of Ambroxol can be increased when it is combined with Mifepristone. The serum concentration of Ambroxol can be increased when it is combined with Stiripentol. The serum concentration of Tolvaptan can be increased when it is combined with Ambroxol. The serum concentration of Cerivastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Lopinavir. The metabolism of Ambroxol can be decreased when combined with Posaconazole. The serum concentration of Ambroxol can be increased when it is combined with Aprepitant. The risk or severity of adverse effects can be increased when Cabergoline is combined with Ambroxol. The risk or severity of adverse effects can be increased when Nicergoline is combined with Ambroxol. The metabolism of Ambroxol can be increased when combined with Phenobarbital. The metabolism of Ambroxol can be decreased when combined with Crizotinib. The serum concentration of Ambroxol can be decreased when it is combined with Mitotane. The serum concentration of Ambroxol can be decreased when it is combined with Vemurafenib. The metabolism of Ambroxol can be increased when combined with Rifapentine. The metabolism of Ambroxol can be decreased when combined with Telaprevir. The serum concentration of Ambroxol can be increased when it is combined with Ivacaftor. The metabolism of Ambroxol can be decreased when combined with Verapamil. The metabolism of Ambroxol can be decreased when combined with Isavuconazonium. The metabolism of Ambroxol can be decreased when combined with Rucaparib. The metabolism of Ambroxol can be decreased when combined with Ticlopidine. The metabolism of Ambroxol can be decreased when combined with Fluvoxamine. The metabolism of Ambroxol can be decreased when combined with Nefazodone. The metabolism of Ambroxol can be decreased when combined with Itraconazole. The risk or severity of adverse effects can be increased when Lisuride is combined with Ambroxol. The risk or severity of adverse effects can be increased when Metergoline is combined with Ambroxol. The metabolism of Ambroxol can be increased when combined with Lumacaftor. The metabolism of Ambroxol can be decreased when combined with Idelalisib. The serum concentration of Ambroxol can be decreased when it is combined with Dabrafenib. The serum concentration of Bosutinib can be increased when it is combined with Ambroxol. The serum concentration of Ambroxol can be decreased when it is combined with Siltuximab. The serum concentration of Ambroxol can be increased when it is combined with Palbociclib. The serum concentration of Ambroxol can be increased when it is combined with Netupitant. The serum concentration of Ibrutinib can be increased when it is combined with Ambroxol. The risk or severity of adverse effects can be increased when Methylergometrine is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Voriconazole. The metabolism of Ambroxol can be increased when combined with Carbamazepine. The serum concentration of Rosuvastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Imatinib. The metabolism of Ambroxol can be decreased when combined with Sildenafil. The serum concentration of Ubidecarenone can be increased when it is combined with Ambroxol.